(VIANEWS) – Shares of Pacific Biosciences of California (PACB) dropped 6.92% to $30.81 at 14:19 EST on Tuesday, following the last session’s upward trend. NASDAQ Composite is sliding 0.56% to $14,776.81, following the last session’s upward trend. This seems, up until now, a somewhat bearish trend trading session today.

Pacific Biosciences of California’s last close was $33.10, 38.35% below its 52-week high of $53.69.

Volume

Today’s last reported volume for Pacific Biosciences of California is 872083 which is 62.03% below its average volume of 2296882.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 75% for the ongoing quarter and 68.3% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 33.3% and a negative 50%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current volatility was a positive 0.15%, a negative 0.71%, and a positive 3.47%, respectively.

Pacific Biosciences of California’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.39% (last week), 3.31% (last month), and 3.47% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $30.81 at 14:19 EST, way below its 52-week high of $53.69 and way above its 52-week low of $4.43.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s value is under its 50-day moving average of $31.44 and under its 200-day moving average of $31.60.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here